← FDA Drug Approvals (Drugs@FDA)

ALVIMOPAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2019-12-19

Drug application

FDA Application #

ANDA208295

Application type

Abbreviated New Drug Application (Generic)

Brand name

ALVIMOPAN

Generic name

ALVIMOPAN

Active ingredients

ALVIMOPAN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

WATSON LABS TEVA

Manufacturer

Actavis Pharma, Inc.

First approval

2019-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown